Resona Asset Management Co. Ltd. Acquires Shares of 36,841 Henry Schein, Inc. (NASDAQ:HSIC)

Resona Asset Management Co. Ltd. bought a new position in Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 36,841 shares of the company’s stock, valued at approximately $2,556,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Versant Capital Management Inc lifted its position in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares in the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares in the last quarter. Quent Capital LLC lifted its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the last quarter. Finally, City State Bank purchased a new position in Henry Schein in the 4th quarter worth about $55,000. Institutional investors own 96.62% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Analyst Ratings Changes

HSIC has been the topic of a number of recent analyst reports. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Finally, StockNews.com raised Henry Schein from a “hold” rating to a “buy” rating in a report on Wednesday. Five investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Trading Up 5.5 %

Shares of NASDAQ:HSIC opened at $66.16 on Thursday. The stock has a 50 day moving average of $72.55 and a 200 day moving average of $72.32. The company has a market cap of $8.22 billion, a PE ratio of 27.23, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.66 earnings per share. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.